Clinical Trial Update: A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of LNK01001 in adults with ankylosing spondylitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• LNK01001

Snippet

Sponsor: Lynk Pharmaceuticals Co., Ltd | Conditions: Ankylosing Spondylitis | Phase 3 | Status: RECRUITING